Physician profile
Amy Mellor
NPI 1487714770
$10,929.43
in general payments reported to CMS, 2019-2025
56 companies · $2,781 in 2025
The $2,781 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2020: $475 · 2021: $1,722 · 2022: $1,511 · 2023: $1,556 · 2024: $2,041 · 2025: $2,781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,376.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,609.90 | 2019-2025 | |
| Biogen, INC. | $809.93 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Pfizer INC. | $619.79 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $549.82 | 2019-2025 | |
| Emd Serono, INC. | $523.27 | 2019-2025 | Mavenclad |
| Neurocrine Biosciences, INC. | $485.44 | 2020-2025 | Ingrezza, Ongentys |
| Lilly USA, LLC | $481.95 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Eisai INC. | $464.66 | 2019-2025 | |
| Ucb, INC. | $421.12 | 2019-2025 | Nayzilam, Briviact, Zilbrysq |
| Argenx US, INC. | $418.49 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Amgen INC. | $299.37 | 2019-2023 | Aimovig |
| Amneal Pharmaceuticals LLC | $267.08 | 2019-2024 | Rytary, Ongentys |
| Otsuka America Pharmaceutical, INC. | $255.56 | 2023-2025 | Nuedexta, Rexulti |
| Teva Pharmaceuticals USA, INC. | $244.44 | 2019-2025 | Austedo Xr, Austedo Xr |
| Allergan, INC. | $237.06 | 2019-2021 |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Mellor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.